<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34867791</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2392</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in endocrinology</Title><ISOAbbreviation>Front Endocrinol (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Follow Your Nose: A Key Clue to Understanding and Treating COVID-19.</ArticleTitle><Pagination><StartPage>747744</StartPage><MedlinePgn>747744</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">747744</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fendo.2021.747744</ELocationID><Abstract><AbstractText>This paper suggests that ATP release induced by the SARS-CoV-2 virus plays a key role in the genesis of the major symptoms and complications of COVID-19. Infection of specific cells which contain the Angiotensin-Converting Enzyme 2 (ACE2) receptor results in a loss of protection of the Mineralocorticoid Receptor (MR). Local activation by cortisol stimulates the release of ATP initially into the basolateral compartment and then by lysosomal exocytosis from the cell surface. This then acts on adjacent cells. In the nose ATP acts as a nociceptive stimulus which results in anosmia. It is suggested that a similar paracrine mechanism is responsible for the loss of taste. In the lung ATP release from type 2 alveolar cells produces the non-productive cough by acting on purinergic receptors on adjacent neuroepithelial cells and activating, <i>via</i> the vagus, the cough reflex. Infection of endothelial cells results in the exocytosis of WeibelPalade bodies. These contain the Von Willebrand Factor responsible for micro-clotting and angiopoietin-2 which increases vascular permeability and plays a key role in the Acute Respiratory Distress Syndrome. To test this hypothesis this paper reports proof of concept studies in which MR blockade using spironolactone and low dose dexamethasone (SpiDex) was given to PCR-confirmed COVID-19 patients. In 80 patients with moderate to severe respiratory failure 40 were given SpiDex and 40 conventional treatment with high dose dexamethasone (HiDex). There was 1 death in the HiDex group and none in the SpiDex. As judged by clinical, biochemical and radiological parameters there were clear statistically significant benefits of SpiDex in comparison to HiDex. A further 20 outpatients with COVID-19 were given SpiDex. There was no control group and the aim was to demonstrate safety. No adverse effects were noted and no patient became hyperkalaemic. 90% were asymptomatic at 10 days. The very positive results suggest that blockade of the MR can produce major benefit in COVID19 patients. Further larger controlled studies of inpatients and outpatients are required not only for SARS-CoV-2 infection per se but also to determine if this treatment affects the incidence of Long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Edwards, Klekot, Halugan and Korchev.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Edwards</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hammersmith Hospital, Imperial College, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klekot</LastName><ForeName>Oleksandra</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Clinical Pharmacology Department, Vinnytsia National Pirogov Memorial Medical University, Vinnytsia, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halugan</LastName><ForeName>Larisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Infection Department, Vinnytsia State Clinical Hospital #3, Vinnytsia, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korchev</LastName><ForeName>Yuri</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Hammersmith Hospital, Imperial College, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Endocrinol (Lausanne)</MedlineTA><NlmUniqueID>101555782</NlmUniqueID><ISSNLinking>1664-2392</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C586513">ANGPT2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D042702">Angiopoietin-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C561839">NR3C2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018161">Receptors, Mineralocorticoid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014841">von Willebrand Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>27O7W4T232</RegistryNumber><NameOfSubstance UI="D013148">Spironolactone</NameOfSubstance></Chemical><Chemical><RegistryNumber>7S5I7G3JQL</RegistryNumber><NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance></Chemical><Chemical><RegistryNumber>8L70Q75FXE</RegistryNumber><NameOfSubstance UI="D000255">Adenosine Triphosphate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Front Endocrinol (Lausanne). 2021 Dec 16;12:830164. doi: 10.3389/fendo.2021.830164</RefSource><PMID Version="1">34975774</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000255" MajorTopicYN="N">Adenosine Triphosphate</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042702" MajorTopicYN="N">Angiopoietin-2</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086582" MajorTopicYN="N">Anosmia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003907" MajorTopicYN="N">Dexamethasone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059225" MajorTopicYN="Y">Nociception</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018161" MajorTopicYN="N">Receptors, Mineralocorticoid</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013148" MajorTopicYN="N">Spironolactone</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063189" MajorTopicYN="Y">Symptom Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014841" MajorTopicYN="N">von Willebrand Factor</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ATP - adenosine triphosphate</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">anosmia and ageusia</Keyword><Keyword MajorTopicYN="N">mineralocorticoid receptor</Keyword><Keyword MajorTopicYN="N">spironolactone and dexamethasone</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>6</Day><Hour>9</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34867791</ArticleId><ArticleId IdType="pmc">PMC8636831</ArticleId><ArticleId IdType="doi">10.3389/fendo.2021.747744</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Borsetto D, Hopkins C, Philips V, Obholzer R, Tirelli G, Polesel J, et al. . Self-Reported Alteration of Sense of Smell or Taste in Patients With COVID-19: A Systematic Review and Meta-Analysis on 3563 Patients. Rhinology (2020) 58(5):1&#x2013;7. doi:&#xa0;10.4193/Rhin20.185</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin20.185</ArticleId><ArticleId IdType="pubmed">32626853</ArticleId></ArticleIdList></Reference><Reference><Citation>Han AY, Mukdad L, Long JL, Lopez IA. Anosmia in COVID-19: Mechanisms and Significance. Chem Senses (2020) 45(6):423&#x2013;8. doi:&#xa0;10.1093/chemse/bjaa040</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjaa040</ArticleId><ArticleId IdType="pmc">PMC7449368</ArticleId><ArticleId IdType="pubmed">32556089</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. . Olfactory and Gustatory Dysfunctions as a Clinical Presentation of Mild-to-Moderate Forms of the Coronavirus Disease (COVID-19): A Multicenter European Study. Eur Arch Otorhinolaryngol (2020) 277(8):2251&#x2013;61. doi:&#xa0;10.1007/s00405-020-05965-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-05965-1</ArticleId><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann DH, Tsukahara T, Weinreb C, Lipovsek M, Van Den Berge K, Gong B, et al. . Nonneuronal Expression of SARS-CoV-2 Entry Genes in the Olfactory System Suggests Mechanisms Underlying COVID-19-Associated Anosmia. Sci Adv (2020) 6(31):1&#x2013;29. doi:&#xa0;10.1126/sciadv.abc5801</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc5801</ArticleId><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinska K, Jakubowska P, Von Bartheld CS, Butowt R. Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends With Age. ACS Chem Neurosci (2020) 11(11):1555&#x2013;62. doi:&#xa0;10.1021/acschemneuro.0c00210</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00210</ArticleId><ArticleId IdType="pmc">PMC7241737</ArticleId><ArticleId IdType="pubmed">32379417</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Zhou J, Marshall B, Rekaya R, Ye K, Liu HX. SARS-CoV-2 Receptor ACE2 Is Enriched in a Subpopulation of Mouse Tongue Epithelial Cells in Nongustatory Papillae But Not in Taste Buds or Embryonic Oral Epithelium. ACS Pharmacol Transl Sci (2020) 3(4):749&#x2013;58. doi:&#xa0;10.1021/acsptsci.0c00062</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsptsci.0c00062</ArticleId><ArticleId IdType="pmc">PMC7409941</ArticleId><ArticleId IdType="pubmed">32821883</ArticleId></ArticleIdList></Reference><Reference><Citation>Usami Y, Hirose K, Okumura M, Toyosawa S, Sakai T. Brief Communication: Immunohistochemical Detection of ACE2 in Human Salivary Gland. Oral Sci Int (2021) 18(2):101&#x2013;4. doi:&#xa0;10.1002/osi2.1085</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/osi2.1085</ArticleId><ArticleId IdType="pmc">PMC7537151</ArticleId><ArticleId IdType="pubmed">33041626</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards C. New Horizons: Does Mineralocorticoid Receptor Activation by Cortisol Cause ATP Release and COVID-19 Complications? J Clin Endocrinol Metab (2021) 106(3):622&#x2013;35. doi:&#xa0;10.1210/clinem/dgaa874</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa874</ArticleId><ArticleId IdType="pmc">PMC7798966</ArticleId><ArticleId IdType="pubmed">33249452</ArticleId></ArticleIdList></Reference><Reference><Citation>Kern RC, Pitovski DZ. Localization of 11/&#x3b2;-Hydroxysteroid Dehydrogenase: Specific Protector of the Mineralocorticoid Receptor in Mammalian Olfactory Mucosa. Acta Otolaryngol (1997) 117(5):738&#x2013;43. doi:&#xa0;10.3109/00016489709113470</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00016489709113470</ArticleId><ArticleId IdType="pubmed">9349873</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbrecht MR, Klein JM, McCarthy TA, Schmidt TJ, Krozowski ZS, Snyder JM. 11-&#x3b2; Hydroxysteroid Dehydrogenase Type 2 in Human Adult and Fetal Lung and its Regulation by Sex Steroids. Pediatr Res (2007) 62(1):26&#x2013;31. doi:&#xa0;10.1203/PDR.0b013e3180676cf3</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/PDR.0b013e3180676cf3</ArticleId><ArticleId IdType="pubmed">17515840</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Yang P, Liu K, Guo F, Zhang Y, Zhang G, et al. . Paradoxical Mineralocorticoid Receptor Activation and Left Ventricular Diastolic Dysfunction Under High Oxidative Stress Conditions. J Hypertens (2008) 26(7):1453&#x2013;62. doi:&#xa0;10.1097/HJH.0b013e328300a232</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0b013e328300a232</ArticleId><ArticleId IdType="pubmed">18551023</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagase M, Matsui H, Shibata S, Gotoda T, Fujita T. Salt-Induced Nephropathy in Obese Spontaneously Hypertensive Rats via Paradoxical Activation of the Mineralocorticoid Receptor: Role of Oxidative Stress. Hypertension (2007) 50(5):877&#x2013;83. doi:&#xa0;10.1161/HYPERTENSIONAHA.107.091058</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.107.091058</ArticleId><ArticleId IdType="pubmed">17875821</ArticleId></ArticleIdList></Reference><Reference><Citation>Funder JW. Aldosterone, Mineralocorticoid Receptors and Vascular Inflammation. Mol Cell Endocrinol (2004) 217(1-2):263&#x2013;9. doi:&#xa0;10.1016/j.mce.2003.10.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2003.10.054</ArticleId><ArticleId IdType="pubmed">15134827</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart PM, Corrie JE, Shackleton CH, Edwards CR. Syndrome of Apparent Mineralocorticoid Excess. A Defect in the Cortisol-Cortisone Shuttle. J Clin Invest (1988) 82(1):340&#x2013;9. doi:&#xa0;10.1172/JCI113592</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI113592</ArticleId><ArticleId IdType="pmc">PMC303514</ArticleId><ArticleId IdType="pubmed">3164727</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart PM, Valentino R, Wallace AM, Burt D, Shackleton CHL, Edwards CRW. Mineralocorticoid Activity of Liquorice: 11-Beta-Hydroxysteroid Dehydrogenase Deficiency Comes of Age. Lancet (1987) 330(8563):821&#x2013;4. doi:&#xa0;10.1016/S01406736(87)91014-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S01406736(87)91014-2</ArticleId><ArticleId IdType="pubmed">2889032</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards CRW, Burt D, Mcintyre MA, De Kloet ER, Stewart PM, Brett L, et al. . Localisation of 11B-Hydroxysteroid Dehydrogenase-Tissue Specific Protector of the Mineralocorticoid Receptor. Lancet (1988) 332(8618):986&#x2013;9. doi:&#xa0;10.1016/S0140-6736(88)90742-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(88)90742-8</ArticleId><ArticleId IdType="pubmed">2902493</ArticleId></ArticleIdList></Reference><Reference><Citation>Winardi Sutanto J, van Eekelen AM, Reul JMHM, de Kloel ER. Species-Specific Topography of Corticosteroid Receptor Types in Rat and Hamster Brain. Neuroendocrinology (1988) 47(5):398&#x2013;404. doi:&#xa0;10.1159/000124954</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000124954</ArticleId><ArticleId IdType="pubmed">3399027</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorelik J, Zhang Y, S&#xe1;nchez D, Shevchuk A, Frolenkov G, Lab M, et al. . Aldosterone Acts via an ATP Autocrine/Paracrine System: The Edelman ATP Hypothesis Revisited. Proc Natl Acad Sci U S A (2005) 102(42):15000&#x2013;5. doi:&#xa0;10.1073/pnas.0507008102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0507008102</ArticleId><ArticleId IdType="pmc">PMC1257717</ArticleId><ArticleId IdType="pubmed">16230642</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirley DG, Bailey MA, Unwin RJ. In Vivo Stimulation of Apical P2 Receptors in Collecting Ducts: Evidence for Inhibition of Sodium Reabsorption. Am J Physiol Renal Physiol (2005) 288(6 57-6):1243&#x2013;8. doi:&#xa0;10.1152/ajprenal.00152.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00152.2004</ArticleId><ArticleId IdType="pubmed">15687251</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Gu Y, Wen R, Shen F, Tian HL, Yang GY, et al. . Lysosome Exocytosis is Involved in Astrocyte ATP Release After Oxidative Stress Induced by H2O2. Neurosci Lett (2019) 705:251&#x2013;8. doi:&#xa0;10.1016/j.neulet.2019.03.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.03.046</ArticleId><ArticleId IdType="pubmed">30928480</ArticleId></ArticleIdList></Reference><Reference><Citation>Eddy MC, Eschle BK, Barrows J, Hallock RM, Finger TE, Delay ER. Double P2X2/P2X3 Purinergic Receptor Knockout Mice do Not Taste NaCl or the Artificial Sweetener SC45647. Chem Senses (2009) 34(9):789&#x2013;97. doi:&#xa0;10.1093/chemse/bjp068</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjp068</ArticleId><ArticleId IdType="pmc">PMC2762055</ArticleId><ArticleId IdType="pubmed">19833661</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegg CC, Greenwood D, Hua W, Han P, Lucero MT. Activation of Purinergic Receptor Subtypes Modulates Odor Sensitivity. J Neurosci (2003) 23(23):8291&#x2013;301. doi:&#xa0;10.1523/jneurosci.23-23-08291.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.23-23-08291.2003</ArticleId><ArticleId IdType="pmc">PMC2976511</ArticleId><ArticleId IdType="pubmed">12967991</ArticleId></ArticleIdList></Reference><Reference><Citation>Finger TE, Danilova V, Barrows J, Finger TE, Danilova V, Barrows J, et al. . Communication From Taste Buds to Gustatory Nerves. Science (80- ) (2005) 310(5753):1495&#x2013;9. doi:&#xa0;10.1126/science.1118435</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1118435</ArticleId><ArticleId IdType="pubmed">16322458</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha P, Matthay M, Calfee C. Is a &#x201c;Cytokine Storm&#x201d; Relevant to COVID-19? JAMA Intern Med (2020) 180:1152&#x2013;4. doi:&#xa0;10.1001/jamainternmed.2020.3313</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.3313</ArticleId><ArticleId IdType="pubmed">32602883</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman TL, Swartz TH. Targeting the NLRP3 Inflammasome in Severe COVID-19. Front Immunol (2020) 11:1518(June). doi:&#xa0;10.3389/fimmu.2020.01518</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01518</ArticleId><ArticleId IdType="pmc">PMC7324760</ArticleId><ArticleId IdType="pubmed">32655582</ArticleId></ArticleIdList></Reference><Reference><Citation>Amores-Iniesta J, Barber&#xe0;-Cremades M, Mart&#xed;nez CM, Pons JA, Revilla-Nuin B, Mart&#xed;nezAlarc&#xf3;n L, et al. . Extracellular ATP Activates the NLRP3 Inflammasome and Is an Early Danger Signal of Skin Allograft Rejection. Cell Rep (2017) 21(12):3414&#x2013;26. doi:&#xa0;10.1016/j.celrep.2017.11.079</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.11.079</ArticleId><ArticleId IdType="pmc">PMC5746605</ArticleId><ArticleId IdType="pubmed">29262323</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong Y J, Chaupin DF, Matsushita K, Yamakuchi M, Cameron SJ, Morrell CN, et al. . Aldosterone Activates Endothelial Exocytosis. Proc Natl Acad Sci U S A (2009) 106:37823787. doi:&#xa0;10.1073/pnas.0804037106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0804037106</ArticleId><ArticleId IdType="pmc">PMC2656157</ArticleId><ArticleId IdType="pubmed">19223584</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmetaj-Shala B, Peacock TP, Baillon L, Swann OC, Gashaw H, Barclay WS, et al. . Resistance of Endothelial Cells to SARS-CoV-2 Infection In Vitro . bioRxiv (2020). doi:&#xa0;10.1101/2020.11.08.372581</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.08.372581</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko N, Satta S, Komuro Y, Muthukrishnan SD, Kakarla V, Guo L, et al. . Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection. Stroke (2021) 52:260&#x2013;70. doi:&#xa0;10.1161/STROKEAHA.120.032764</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.032764</ArticleId><ArticleId IdType="pmc">PMC7769899</ArticleId><ArticleId IdType="pubmed">33161843</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J, Hu B, Qu H, Wang L, Huang X, Li M, et al. . Upregulation of Angiotensin Converting Enzyme 2 by Shear Stress Reduced Inflammation and Proliferation in Vascular Endothelial Cells. Biochem Biophys Res Commun (2020) 525(3):812&#x2013;8. doi:&#xa0;10.1016/j.bbrc.2020.02.151</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.02.151</ArticleId><ArticleId IdType="pubmed">32169277</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz MA, Vestweber D, Simons M. A Unifying Concept in Vascular Health and Disease. Science (80- ) (2018) 360(6386):270&#x2013;1. doi:&#xa0;10.1126/science.aat3470</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat3470</ArticleId><ArticleId IdType="pmc">PMC6295341</ArticleId><ArticleId IdType="pubmed">29674582</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicenzi M, Ruscica M, Iodice S, Rota I, Ratti A, Di Cosola R, et al. . The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients. J Clin Med (2020) 9(9):2943. doi:&#xa0;10.3390/jcm9092943</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9092943</ArticleId><ArticleId IdType="pmc">PMC7564548</ArticleId><ArticleId IdType="pubmed">32933039</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin EM, Cadegiani FA, Goren A, Wambier CG. Early Antiandrogen Therapy ( EAT ) for COVID-19 With Dutasteride or Spironolactone Results in Faster Virological and Clinical Remission: A Post Hoc Analysis of 475 Patients Treated W ... Early Antiandrogen Therapy ( EAT ) for COVID-19 With Dutasteride or. Research Gate Preprint (2020) (December). doi:&#xa0;10.13140/RG.2.2.22372.19848</Citation><ArticleIdList><ArticleId IdType="doi">10.13140/RG.2.2.22372.19848</ArticleId></ArticleIdList></Reference><Reference><Citation>Funder JW. Mineralocorticoid Receptor Activation and Oxidative Stress. Hypertension (2007) 50(5):840&#x2013;1. doi:&#xa0;10.1161/HYPERTENSIONAHA.107.098012</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.107.098012</ArticleId><ArticleId IdType="pubmed">17923584</ArticleId></ArticleIdList></Reference><Reference><Citation>Keidar S, Kaplan M, Pavlotzky E, Coleman R, Hayek T, Hamoud S, et al. . Aldosterone Administration to Mice Stimulates Macrophage NADPH Oxidase and Increases Atherosclerosis Development A Possible Role for Angiotensin-Converting Enzyme and the Receptors for Angiotensin II and Aldosterone. Circulation (2004) 109:2213&#x2013;20. doi:&#xa0;10.1161/01.CIR.0000127949.05756.9D</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000127949.05756.9D</ArticleId><ArticleId IdType="pubmed">15123520</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby. Dexamethasone in Hospitalized Patients With Covid-19 &#x2014; Preliminary Report. N Engl J Med (2020). doi:&#xa0;10.1056/nejmoa2021436</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>University of Oxford . Low-Cost Dexamethasone Reduces Death by Up to One Third in Hospitalised Patients With Severe - The RECOVERY Trial. Oxford; (2021) 384:693&#x2013;704.</Citation></Reference><Reference><Citation>Smilowitz NR, Kunichoff D, Garshick M, Shah B, Pillinger M, Hochman JS, et al. . C-Reactive Protein and Clinical Outcomes in Patients With COVID-19. Eur Heart J (2021) 42:2270&#x2013;9. doi:&#xa0;10.1093/eurheartj/ehaa1103</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa1103</ArticleId><ArticleId IdType="pmc">PMC7928982</ArticleId><ArticleId IdType="pubmed">33448289</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S, Dellibovi-Ragheb TA, Kerviel A, Pak E, Qiu Q, Fisher M, et al. . &#x3b2;-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway. Cell (2020) 183(6):1520&#x2013;1535.e14. doi:&#xa0;10.1016/j.cell.2020.10.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.039</ArticleId><ArticleId IdType="pmc">PMC7590812</ArticleId><ArticleId IdType="pubmed">33157038</ArticleId></ArticleIdList></Reference><Reference><Citation>Peti-peterdi J, Bell PD. Regulation of Macula Densa Na:H Exchange by Angiotensin II. Kidney Int (1998) 54(6):2021&#x2013;8. doi:&#xa0;10.1046/j.1523-1755.1998.00200.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.1998.00200.x</ArticleId><ArticleId IdType="pubmed">9853267</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao Y, Li G, Zhang X, Xu H, Abraham SN. A TRP Channel Senses Lysosome Neutralization by Pathogens to Trigger Their Expulsion. Cell (2015) 161(6):1306&#x2013;19. doi:&#xa0;10.1016/j.cell.2015.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.05.009</ArticleId><ArticleId IdType="pmc">PMC4458218</ArticleId><ArticleId IdType="pubmed">26027738</ArticleId></ArticleIdList></Reference><Reference><Citation>Keidar S, Gamliel-Lazarovich A, Kaplan M, Pavlotzky E, Hamoud S, Hayek T, et al. . Mineralocorticoid Receptor Blocker Increases Angiotensin-Converting Enzyme 2 Activity in Congestive Heart Failure Patients. Circ Res (2005) 97(9):946&#x2013;53. doi:&#xa0;10.1161/01.RES.0000187500.24964.7A</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000187500.24964.7A</ArticleId><ArticleId IdType="pubmed">16179584</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>